MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202617054474 A) filed by Shenzhen Salubris Pharmaceuticals Co. , Ltd on April 29, 2026, for Glp-1 Compound, And Preparation Method Therefor And Use Thereof.
Inventors include Xu, Wenjie; Lian, Xiaolei; Xing, Wei; Zhang, Shu; Xiao, Ying; Cao, Dapeng; Zhu, Ruihua; Hua, Huaijie; and Li, Qinze.
The application for the patent was published on June 05, 2026, under issue no. 23/2026.
Abstract: The present invention belongs to the technical field of therapeutic peptides, and relates to a compound as shown in general formula (I), or a racemate thereof, or an isomer thereof, or a pharmaceutically acceptable salt thereof, as a GLP-1 compound, and the use thereof in the treatment of diseases.
Disclaimer: Curated by HT Syndication.
